Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02143401 |
Title | Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Mayo Clinic in Arizona | Scottsdale | Arizona | 85259 | United States | Details | |
University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
UCHealth University of Colorado Hospital | Aurora | Colorado | 80045 | United States | Details | |
Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | United States | Details | |
University of Iowa/Holden Comprehensive Cancer Center | Iowa City | Iowa | 52242 | United States | Details | |
University of Maryland/Greenebaum Cancer Center | Baltimore | Maryland | 21201 | United States | Details | |
Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | United States | Details | |
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center | New York | New York | 10032 | United States | Details | |
Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | United States | Details | |
M D Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |